|
2.4治疗 一旦明确诊断,最重要的治疗措施是立即停止正在使用的滴眼剂,减少局部化学和物理刺激，适量使用不含防腐剂的人工泪液,或改用低毒性药物及口服替代药物。药源性眼表疾病多由眼局部不合理用药引起,合理规范用药、预防发生是关键。临床医生在用药过程中应该综合考虑眼药的降眼压效应，毒副作用，患者耐受性，依从性等各个方面,并根据患者的情况选择合适的联合用药方案。当出现眼表疾病，或眼表疾病控制不满意、加重时均应考虑药物毒性的发生。
【参考文献】
1 Qiu GH, Liu XY, Wu ZQ. Retrospection and expectation on drug management of glaucoma. Int J Ophthalmol(Guoji Yanke Zazhi)2007;7(3): 754758
2 Wilson FM. Adverse external ocular effects of topical ophthalmic therapy: an epidemiologic, laboratory, and clinical study. Trans Am Ophthalmol
Soc1983;81:854965
3 Bernauer W. Ocular surface problems following topical medication.
Klin Monatsbl Augenheilkd2002;219(4):240242
4 Bensoussan L, Blondin C, Baudouin C, et al. Flow cytometric analysis of HLADR, IL 6 and IL8 expression by conjunctival epithelial cells from patients with prolonged topical antiglaucoma treatments. J Fr Ophthalmol 2003;26(8):782789
5 Baudouin C, Pisella PJ, Fillacier K, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology1999;106(3):556563
6 Becquet F, Goldschild M, Moldovan MS, et al. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res1998;17(4):419 425
7 Eleftheriadis H, Cheong M, Sandeman S, et al. Corneal toxicity secondary to inadvertent use of benzalkonium chloride preserved viscoelastic material in cataract surgery. Br J Ophthalmol2002;86(3):299305
8张婧,卢艳.抗青光眼药的使用及其副作用.眼科新进展2007;27(9):707710
9 Levrat F, Pisella PJ, Baudouin C. Clinical tolerance of antiglaucoma eyedrops with and without a preservative. Results of an unpublished survey in Europe. J Fr Ophtalmol1999;22(2):186191
上一页 [1] [2] |
